DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy

Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical Affairs and Scientific Communications (DIA MASC) forum I attended in March 2025, along with a focus on how we can utilize these tools to achieve impactful, engaging, and scientifically accurate communications that resonate with healthcare providers (HCPs) and patients. Along…...
Read More

Top Stories

Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...
AI in Medical Affairs & Medical Communications

Science, AI, and Human Ingenuity Converge to

Today, we're witnessing an unprecedented convergence of...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Building public trust in pharma

3 Factors That Will Help Pharma Build Public Trust

Pharma must engage with patients at all levels to build public trust...
Image for the graphical abstracts blog by Cactus Life Sciences

Reel Your Audience in with a Visual Abstract

Graphical abstracts allow room for science communication to be reimagined in a range of creative...
Vaccine

Role of Scientific Communication and Medical Professionals in Combating Vaccine Hesitancy

Read an insightful discussion from the latest ISMPP conference on how science communication and medical...
UX design for scientific writing

Future of Scientific Writing and Journal Articles with UX Design

Take a look at some ideas and examples on how user experience design can be...
Pexels Anna Shvets

How Academic Societies Are Embracing the New Digital World: A Look at the Years Gone by and Ahead

The pandemic has required traditional academic societies to rapidly pivot to digital formats for conferences...
Preprints, medRxiv, and pharma

Preprints, MedRxiv, and Pharma – An Overview

Non-peer reviewed and unpublished manuscripts, aka preprints, are slowly being embraced by the pharma industry...

Learn more ABOUT our company.